S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13

Phreesia Stock Forecast, Price & News

-1.83 (-3.26%)
(As of 12/3/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
458,070 shs
Average Volume
419,861 shs
Market Capitalization
$2.76 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive PHR News and Ratings via Email

Sign-up to receive the latest news and ratings for Phreesia and its competitors with MarketBeat's FREE daily newsletter.

Phreesia logo

About Phreesia

Phreesia, Inc. is a healthcare software company, which engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in New York, NY.


Phreesia, Inc. (NYSE:PHR) SVP Sells $261,371.70 in Stock
November 9, 2021 |  americanbankingnews.com
Phreesia Reaches Analyst Target Price
November 7, 2021 |  nasdaq.com
Notable Phreesia Insider Trades $410K In Company Stock
November 3, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Business services, not elsewhere classified
Year Founded

Sales & Book Value

Annual Sales
$148.68 million
Book Value
$5.96 per share


Net Income
$-27.29 million
Pretax Margin




Free Float
Market Cap
$2.76 billion
Not Optionable

Company Calendar

Last Earnings
Next Earnings (Confirmed)
Fiscal Year End


Overall MarketRank

2.32 out of 5 stars

Medical Sector

279th out of 1,390 stocks

Business Services, Not Elsewhere Classified Industry

44th out of 137 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -

Phreesia (NYSE:PHR) Frequently Asked Questions

Is Phreesia a buy right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Phreesia in the last year. There are currently 1 hold rating and 12 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Phreesia stock.
View analyst ratings for Phreesia
or view top-rated stocks.

How has Phreesia's stock price been impacted by Coronavirus (COVID-19)?

Phreesia's stock was trading at $23.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PHR stock has increased by 130.9% and is now trading at $54.27.
View which stocks have been most impacted by COVID-19

When is Phreesia's next earnings date?

Phreesia is scheduled to release its next quarterly earnings announcement on Wednesday, December 8th 2021.
View our earnings forecast for Phreesia

How can I listen to Phreesia's earnings call?

Phreesia will be holding an earnings conference call on Thursday, December 9th at 8:45 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Phreesia's earnings last quarter?

Phreesia, Inc. (NYSE:PHR) posted its quarterly earnings results on Tuesday, August, 31st. The company reported ($0.48) earnings per share for the quarter, missing the consensus estimate of ($0.22) by $0.26. The firm earned $51.01 million during the quarter, compared to the consensus estimate of $47.22 million. Phreesia had a negative net margin of 27.94% and a negative trailing twelve-month return on equity of 13.18%. The business's quarterly revenue was up 45.7% compared to the same quarter last year. During the same period last year, the firm earned ($0.17) EPS.
View Phreesia's earnings history

What guidance has Phreesia issued on next quarter's earnings?

Phreesia issued an update on its FY 2022 earnings guidance on Wednesday, September, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $195 million-$198 million, compared to the consensus revenue estimate of $193.42 million.

What price target have analysts set for PHR?

13 analysts have issued 1-year price targets for Phreesia's stock. Their forecasts range from $59.00 to $81.00. On average, they expect Phreesia's share price to reach $71.25 in the next year. This suggests a possible upside of 31.3% from the stock's current price.
View analysts' price targets for Phreesia
or view top-rated stocks among Wall Street analysts.

Who are Phreesia's key executives?

Phreesia's management team includes the following people:
  • Chaim Indig, Chief Executive Officer & Director
  • Evan Roberts, Chief Operating Officer (LinkedIn Profile)
  • Randy Rasmussen, Chief Accounting & Financial Officer
  • Daniel Nathan, Chief Technology Officer
  • Cathy Nathan, VP-Business Systems & Information Technology

What is Chaim Indig's approval rating as Phreesia's CEO?

172 employees have rated Phreesia CEO Chaim Indig on Glassdoor.com. Chaim Indig has an approval rating of 73% among Phreesia's employees.

What other stocks do shareholders of Phreesia own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phreesia investors own include Fastly (FSLY), Zscaler (ZS), Okta (OKTA), DocuSign (DOCU), HealthEquity (HQY), Square (SQ), Appian (APPN), Walt Disney (DIS), Globant (GLOB) and Invitae (NVTA).

When did Phreesia IPO?

(PHR) raised $127 million in an IPO on Thursday, July 18th 2019. The company issued 7,800,000 shares at $15.00-$17.62 per share. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray acted as the underwriters for the IPO.

What is Phreesia's stock symbol?

Phreesia trades on the New York Stock Exchange (NYSE) under the ticker symbol "PHR."

Who are Phreesia's major shareholders?

Phreesia's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.92%), Credit Suisse AG (3.11%), Jennison Associates LLC (2.57%), Invesco Ltd. (1.94%), Rock Springs Capital Management LP (1.91%) and Franklin Resources Inc. (1.84%). Company insiders that own Phreesia stock include Allison C Hoffman, Amy Beth Vanduyn, Chaim Indig, Charles Kallenbach, Cheryl Pegus, Daniel Nathan, David Linetsky, Edward L Cahill, Evan Roberts, Gillian Munson, Mark Douglas Smith, Michael J Davidoff, Michael Weintraub, Polaris Venture Management Co, Scott Perricelli and Thomas Altier.
View institutional ownership trends for Phreesia

Which major investors are selling Phreesia stock?

PHR stock was sold by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Two Sigma Investments LP, Kornitzer Capital Management Inc. KS, Rhenman & Partners Asset Management AB, Two Sigma Advisers LP, Jennison Associates LLC, Stony Point Capital LLC, and Franklin Resources Inc.. Company insiders that have sold Phreesia company stock in the last year include Allison C Hoffman, Amy Beth Vanduyn, Chaim Indig, Cheryl Pegus, David Linetsky, Edward L Cahill, Evan Roberts, Gillian Munson, Mark Douglas Smith, Michael J Davidoff, Michael Weintraub, and Thomas Altier.
View insider buying and selling activity for Phreesia
or view top insider-selling stocks.

Which major investors are buying Phreesia stock?

PHR stock was acquired by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, CI Investments Inc., BlackRock Inc., Geode Capital Management LLC, Goldman Sachs Group Inc., Voya Investment Management LLC, Invesco Ltd., and Segall Bryant & Hamill LLC.
View insider buying and selling activity for Phreesia
or or view top insider-buying stocks.

How do I buy shares of Phreesia?

Shares of PHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Phreesia's stock price today?

One share of PHR stock can currently be purchased for approximately $54.27.

How much money does Phreesia make?

Phreesia has a market capitalization of $2.76 billion and generates $148.68 million in revenue each year. The company earns $-27.29 million in net income (profit) each year or ($1.07) on an earnings per share basis.

How many employees does Phreesia have?

Phreesia employs 827 workers across the globe.

What is Phreesia's official website?

The official website for Phreesia is www.phreesia.com.

Where are Phreesia's headquarters?

How can I contact Phreesia?

Phreesia's mailing address is 432 Park Avenue South 12th Floor, New York NY, 10016. The company can be reached via phone at (888) 654-7473, via email at [email protected], or via fax at 646-607-1776.

This page was last updated on 12/4/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.